rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Zhen Su

Director

Company insider

Files Form 4 as: Director, CytomX Therapeutics; Director, Karyopharm Therapeutics.

In numbers

Trades disclosed
10
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
31 Aug 2023
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CTMX CytomX TherapeuticsDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
KPTI Karyopharm TherapeuticsDirector · Biotechnology · last 21 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026CTMX CytomX Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—59,000 at $0.00filing
17 Jun 2026filed 22 Jun 2026CTMX CytomX Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—59,000 at $0.00filing
21 May 2026filed 26 May 2026KPTI Karyopharm TherapeuticsBiotechnologySEC FORM 4 Code A—15,508 at $0.00filing
21 May 2026filed 26 May 2026KPTI Karyopharm TherapeuticsBiotechnologySEC FORM 4 Code A—15,508 at $0.00filing
11 Jun 2025filed 13 Jun 2025CTMX CytomX Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—38,000 at $0.00filing
28 May 2025filed 29 May 2025KPTI Karyopharm Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—4,600 at $0.00filing
29 May 2024filed 30 May 2024KPTI Karyopharm Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,587 at $0.00filing
15 May 2024filed 17 May 2024CTMX CytomX Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—38,000 at $0.00filing
20 Mar 2024filed 22 Mar 2024CTMX CytomX Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—76,000 at $0.00filing
31 Aug 2023filed 1 Sep 2023KPTI Karyopharm Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—68,000 at $0.00filing

Sectors

No trade we could place in a sector.

Related people

Kristin AbateChief Accounting Officer · Chief Accounting Officer at Karyopharm Therapeutics, filing Form 4 there in the last year
Sean A. McCarthyCEO · CEO at CytomX Therapeutics, filing Form 4 there in the last year
Alejandra CarvajalChief Legal Officer · Chief Legal Officer at CytomX Therapeutics, filing Form 4 there in the last year
Charles S. FuchsPresident, R&D · Director at CytomX Therapeutics, filing Form 4 there in the last year
Stuart PoultonEVP, Chief Development Officer · EVP, Chief Development Officer at Karyopharm Therapeutics, filing Form 4 there in the last year